USANA Health Sciences (USNA) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
20 May, 2026Opening remarks and agenda
Chairman welcomed shareholders, board members, management, and guests, including KPMG representatives, and outlined the meeting's agenda and procedures.
Notice of the meeting, proxy materials, and shareholder list were made available to all shareholders as of March 16, 2026.
Corporate governance
Inspector of Elections was appointed and confirmed, with quorum established at 89% of shares represented.
Three agenda items: election of directors, ratification of KPMG as auditor, and advisory vote on executive compensation.
Board recommended voting in favor of all proposals.
Board and executive committee updates
Slate of directors standing for election included eight individuals, with biographical details provided in the proxy statement.
No other nominations were made; nominations were closed.
Latest events from USANA Health Sciences
- Flat Q1 2026 sales, lower earnings, and strong Rise Wellness growth amid customer declines.USNA
Q1 202612 May 2026 - Omnichannel growth and acquisitions are set to drive over 20% of revenue by 2026.USNA
28th Annual ICR Conference 202620 Apr 2026 - 2026 outlook targets up to 8% sales growth, driven by retail and tech investments.USNA
Q4 202510 Apr 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, with focus on governance and ESG.USNA
Proxy filing7 Apr 2026 - Hiya acquisition and agile innovation drive growth, with China and global markets as key priorities.USNA
Sidoti Small-Cap Virtual Conference3 Feb 2026 - Q2 sales and EPS declined sharply, but strong liquidity supports ongoing strategic initiatives.USNA
Q2 20243 Feb 2026 - Active associate growth and accelerated product innovation drive global expansion and future growth.USNA
Small-Cap Growth Virtual Investor Conference1 Feb 2026 - China drives short-term gains as focus shifts to associates, innovation, and disciplined growth.USNA
Water Tower Research Consumer Products Virtual Investor Conference 20241 Feb 2026 - Q3 2024 net sales declined 6.2% year-over-year, with EPS at $0.56 and cash at $365M.USNA
Q3 202419 Jan 2026